Kaveri Pohlman's Stock Ratings

BTIG Analyst

Kaveri Pohlman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/08/2025

Overall Average Return

-32.4%

Smart Score

26%

Overall Average Return Percentile

6th

Number of Ratings

28
Buy NowGet Alert
08/01/2024MGNXBuy Now
Macrogenics
$1.45
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
06/27/2024GMABBuy Now
Genmab
$19.57140.1%
Kaveri Pohlman25%
$46 → $47MaintainsBuyGet Alert
05/24/2024MGNXBuy Now
Macrogenics
$1.45521.08%
Kaveri Pohlman25%
$24 → $9MaintainsBuyGet Alert
04/17/2024CGEMBuy Now
Cullinan Oncology
$7.64292.67%
Kaveri Pohlman25%
$20 → $30MaintainsBuyGet Alert
04/16/2024XNCRBuy Now
Xencor
$8.17365.12%
Kaveri Pohlman25%
$56 → $38MaintainsBuyGet Alert
03/26/2024NUVBBuy Now
Nuvation Bio
$2.04145.7%
Kaveri Pohlman25%
→ $5UpgradeNeutral → BuyGet Alert
03/21/2024JANXBuy Now
Janux Therapeutics
$24.72150.81%
Kaveri Pohlman25%
→ $62Initiates → BuyGet Alert
03/04/2024MGNXBuy Now
Macrogenics
$1.451556.2%
Kaveri Pohlman25%
$12 → $24MaintainsBuyGet Alert
02/09/2024PYXSBuy Now
Pyxis Oncology
$1.08640.74%
Kaveri Pohlman25%
→ $8Initiates → BuyGet Alert
12/19/2023EXELBuy Now
Exelixis
$35.42-23.77%
Kaveri Pohlman25%
→ $27Initiates → BuyGet Alert
10/13/2023GMABBuy Now
Genmab
$19.57134.99%
Kaveri Pohlman25%
$44 → $46MaintainsBuyGet Alert
09/12/2023AMAMBuy Now
Ambrx Biopharma
Kaveri Pohlman25%
→ $26Initiates → BuyGet Alert
08/24/2023GMABBuy Now
Genmab
$19.57124.78%
Kaveri Pohlman25%
→ $44Initiates → BuyGet Alert
08/23/2023RCUSBuy Now
Arcus Biosciences
$7.83794%
Kaveri Pohlman25%
→ $70ReiteratesBuy → BuyGet Alert
03/21/2023MGNXBuy Now
Macrogenics
$1.45728.1%
Kaveri Pohlman25%
$6 → $12MaintainsBuyGet Alert
11/21/2022CGEMBuy Now
Cullinan Oncology
$7.64161.78%
Kaveri Pohlman25%
→ $20Initiates → BuyGet Alert
11/14/2022ONCSBuy Now
OncoSec Medical
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
08/31/2022STTKBuy Now
Shattuck Labs
$0.851311.6%
Kaveri Pohlman25%
→ $12Initiates → BuyGet Alert
08/02/2022NUVBBuy Now
Nuvation Bio
$2.04
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
07/07/2022CTMXBuy Now
CytomX Therapeutics
$1.08640.74%
Kaveri Pohlman25%
$16 → $8MaintainsBuyGet Alert
06/01/2022NEXIBuy Now
NexImmune
$0.004999900%
Kaveri Pohlman25%
→ $5Initiates → BuyGet Alert
04/20/2022CMPIBuy Now
Checkmate Pharmaceuticals
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
03/30/2022CMPIBuy Now
Checkmate Pharmaceuticals
Kaveri Pohlman25%
$29 → $9MaintainsBuyGet Alert
03/16/2022ONCSBuy Now
OncoSec Medical
Kaveri Pohlman25%
$10 → $5MaintainsBuyGet Alert
02/24/2022ONCTBuy Now
Oncternal Therapeutics
Kaveri Pohlman25%
→ $5Initiates → BuyGet Alert
02/09/2022SONNBuy Now
Sonnet BioTherapeutics
$1.3350.38%
Kaveri Pohlman25%
$5 → $2MaintainsBuyGet Alert
11/15/2021CTMXBuy Now
CytomX Therapeutics
$1.081381.48%
Kaveri Pohlman25%
→ $16Initiates → BuyGet Alert
09/15/2021SONNBuy Now
Sonnet BioTherapeutics
$1.33275.94%
Kaveri Pohlman25%
→ $5Initiates → BuyGet Alert